Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Identifying Novel Aging Targets for Treatment of Delirium
Authors not listed
Wake Forest University Health Sciences · 2018
Abstract
The long-term goal of this research program is to improve understanding of the mechanistic link between Alzheimer's disease (AD) neuropathology, acute delirium, and cognitive impairment following acute respiratory failure. In this pilot study, the study team will establish a prospective cohort of older patients with acute respiratory failure and obtain data on delirium duration, AD imaging and CSF biomarkers, and cognitive outcomes following critical illness.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2018). Identifying Novel Aging Targets for Treatment of Delirium. <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT03682874
Vancouver
Anonymous. Identifying Novel Aging Targets for Treatment of Delirium. Wake Forest University Health Sciences. 2018.
BibTeX
@misc{anon2018Identi,
title = {Identifying Novel Aging Targets for Treatment of Delirium},
author = {Anonymous},
journal = {Wake Forest University Health Sciences},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Seoul National University Hospital 2014
Open access · US-GOV
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
NYU Langone Health 2013
Open access · US-GOV
Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
Georgetown University 2007
Open access · US-GOV
DC Longitudinal Study on Aging and Specimen Bank
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only